Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Fertil Steril. 2023 Aug;120(2):321-332. doi: 10.1016/j.fertnstert.2023.03.001. Epub 2023 Mar 20.
To investigate the impact of recryopreservation on embryo viability and the outcomes of in vitro fertilization (IVF) by comparison with single cryopreservation. There is a lack of consensus and reliable evidence regarding the impact of recryopreservation techniques on human embryos, particularly with respect to embryo viability and IVF outcomes.
Systematic review and meta-analysis.
Not applicable.
INTERVENTION(S): Various databases such as PubMed, Embase, Cochrane Library, and Scopus were searched until October 10, 2022. All comparative studies comparing embryonic and IVF outcomes between repeated and single cryopreservation of embryos were included. The random-effect and fixed-effect meta-analysis models were used to pool the odds ratio (OR) and corresponding 95% confidence intervals (CIs). A subgroup analysis was performed based on different methods of cryopreservation and different times of embryo cryopreservation or transfer.
MAIN OUTCOME MEASURE(S): Outcomes referring to embryo surviva l, IVF outcomes (including clinical pregnancy rate, embryo implantation rate, miscarriage rate, and live birth rate), and neonatal outcomes (including low birth weight rate and preterm birth rate) were evaluated.
RESULT(S): Fourteen studies were eligible for the present meta-analysis, involving 4,525 embryo transfer cycles in total (3,270 cycles with single cryopreservation [control group] and 1,255 with recryopreservation [experimental group]). Decreased embryo survival (OR, 0.51; 95% CI, 0.27-0.96) and clinical pregnancy rates (OR, 0.47; 95% CI, 0.23-0.96) were found in embryos that were recryopreserved by slow freezing. The live birth rate of revitrified embryos was also notably affected (OR, 0.60; 95% CI, 0.38-0.94). Overall, recryopreservation resulted in a decreased live birth rate (OR, 0.67; 95% CI, 0.50-0.90) and an increased miscarriage rate (OR, 1.52; 95% CI, 1.16-1.98) compared with single cryopreservation. No significant difference was found in neonatal outcomes. When embryos were cryopreserved and transferred at the blastocyst stage, both the embryo implantation rate (OR, 0.59; 95% CI, 0.39-0.89) and live birth rate (OR, 0.60; 95% CI, 0.37-0.96) were significantly different between the 2 groups.
CONCLUSION(S): The present meta-analysis suggested that recryopreservation, compared with single cryopreservation, can lead to impaired embryo viability and a lower rate of IVF success, with no affected neonatal outcomes. Clinicians and embryologists should retain a cautious attitude toward recryopreservation strategies.
CRD42022359456.
通过与单次冷冻保存相比,研究复融对胚胎活力和体外受精(IVF)结局的影响。关于复融技术对人类胚胎的影响,目前尚无共识和可靠的证据,特别是在胚胎活力和 IVF 结局方面。
系统评价和荟萃分析。
不适用。
截至 2022 年 10 月 10 日,检索了 PubMed、Embase、Cochrane 图书馆和 Scopus 等各种数据库。所有比较胚胎重复和单次冷冻保存后胚胎和 IVF 结局的研究均被纳入。使用随机效应和固定效应荟萃分析模型来汇总优势比(OR)和相应的 95%置信区间(CI)。根据不同的冷冻保存方法和不同的胚胎冷冻或转移时间进行了亚组分析。
评估胚胎存活率、IVF 结局(包括临床妊娠率、胚胎着床率、流产率和活产率)和新生儿结局(包括低出生体重率和早产率)。
本荟萃分析纳入了 14 项研究,共涉及 4525 个胚胎移植周期(3270 个周期采用单次冷冻保存[对照组],1255 个周期采用复融保存[实验组])。复融后的胚胎存活率(OR,0.51;95%CI,0.27-0.96)和临床妊娠率(OR,0.47;95%CI,0.23-0.96)均降低。复融后冷冻胚胎的活产率也显著受到影响(OR,0.60;95%CI,0.38-0.94)。总体而言,与单次冷冻保存相比,复融保存导致活产率降低(OR,0.67;95%CI,0.50-0.90)和流产率升高(OR,1.52;95%CI,1.16-1.98)。新生儿结局无显著差异。当胚胎在囊胚期进行冷冻和转移时,两组胚胎着床率(OR,0.59;95%CI,0.39-0.89)和活产率(OR,0.60;95%CI,0.37-0.96)均有显著差异。
本荟萃分析表明,与单次冷冻保存相比,复融可能导致胚胎活力受损和 IVF 成功率降低,而新生儿结局不受影响。临床医生和胚胎学家应对复融策略持谨慎态度。
CRD42022359456。